Screening for Atrial Fibrillation, After Ischemic Stroke
Improving Screening for Silent Atrial Fibrillation, After Ischemic Stroke
1 other identifier
observational
250
1 country
3
Brief Summary
The aim of the study is to assess the incidence of patients suffering from ischemic stroke or transient ischemic attacks who have underlying asymptomatic paroxysmal atrial fibrillation. Patients who have suffered an ischemic stroke or transient ischemic attack, without a history of atrial fibrillation, are planned to be included. Starting within 14 days of the ischemic stroke, participating patients are asked to perform 10 second ECG recordings using a handheld ECG device twice daily (mornings and evenings) during 30 days. These recordings are transmitted via telephone to a secure encrypted Internet site. Within these 30 days the participants also perform an ambulatory 24 hour Holter recording. Handheld ECG recordings are evaluated continuously. In case of atrial fibrillation the patient is informed and offered treatment with anti coagulant medication (Warfarin). The investigation is a comparison between 24 hour continuous ECG recordings and short intermittent ECG recordings twice daily over a longer time period to determine which method is the best to detect atrial fibrillation in this patient group. Hypothesis: Short Intermittent ECG recordings over a longer time period is more efficient, compared with continuous 24 hour ECG recordings, in detecting silent paroxysmal AF in patients with an ischemic stroke and without a history of atrial fibrillation.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Jun 2007
Typical duration for all trials
3 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
June 1, 2007
CompletedFirst Submitted
Initial submission to the registry
July 9, 2010
CompletedFirst Posted
Study publicly available on registry
July 12, 2010
CompletedPrimary Completion
Last participant's last visit for primary outcome
November 1, 2010
CompletedStudy Completion
Last participant's last visit for all outcomes
November 1, 2010
CompletedJune 27, 2011
June 1, 2011
3.4 years
July 9, 2010
June 22, 2011
Conditions
Keywords
Study Arms (1)
ischemic stroke, no atrial fibrillation
Patients who have suffered ischemic stroke or transient ischemic attack without known atrial fibrillation
Eligibility Criteria
Patients from hospital strokewards.
You may qualify if:
- No previously diagnosed atrial fibrillation.
- Acute ischemic stroke or transient ischemic attack verified by computed tomography or clinical diagnosis using the National Institute of Health Stroke Score within 14 days of enrollment.
- Ability to understand study instructions both verbal and written.
- Ability to perform and transmit ECG recordings according to study design.
You may not qualify if:
- Previously diagnosed atrial fibrillation.
- Hemorrhagic stroke
- Low compliance
- Pacemaker carrier
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (3)
Halmstad hospital
Halmstad, Halland County, 30180, Sweden
South hospital
Stockholm, Stockholm County, 11883, Sweden
Danderyds hospital AB
Stockholm, Stockholm County, 18288, Sweden
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- STUDY DIRECTOR
Mårten Rosenqvist, M.D.Ph.D.
Karolinska Institutet
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
Study Record Dates
First Submitted
July 9, 2010
First Posted
July 12, 2010
Study Start
June 1, 2007
Primary Completion
November 1, 2010
Study Completion
November 1, 2010
Last Updated
June 27, 2011
Record last verified: 2011-06